Evaluation of cholestasis in Iranian infants less than three months of age

Seyed Mohsen Dehghani1, Neda Efazati2, Iraj Shahramian2

  • 1Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran ; Neonatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Insights

Biliary atresia and neonatal hepatitis are the leading causes of infantile cholestasis in infants under three months in Shiraz, Iran. Early diagnosis is crucial for better outcomes in liver disease management.

Area of Science:

  • Pediatrics
  • Hepatology
  • Neonatology

Background:

  • Cholestatic jaundice in infants often stems from pathological conditions like neonatal hepatitis and biliary atresia.
  • Prompt diagnosis and intervention are vital for managing infantile cholestasis and preventing severe liver disease complications.

Purpose of the Study:

  • To identify the primary etiologies of cholestasis in infants under three months of age in Shiraz, Iran.
  • To contribute to the understanding of pediatric liver disease in the region.

Main Methods:

  • A retrospective analysis of 122 infants diagnosed with cholestasis between 2001 and 2011.
  • Data collected included demographic information, jaundice duration, liver biopsy results, and identified causes of cholestasis.

Main Results:

  • Biliary atresia and idiopathic neonatal hepatitis were the most frequent causes, each accounting for 24.6% of cases.
  • Hepatomegaly (76.4%) and clay-colored stools (44.3%) were common clinical findings.
  • Males constituted 62.3% of the study cohort.

Conclusions:

  • Biliary atresia and neonatal hepatitis are the predominant causes of infantile cholestasis in this Iranian population.
  • Discriminating biliary atresia from other neonatal cholestasis forms is essential for effective treatment and improved prognosis.
Abstract